B7S1, a Novel B7 Family Member that Negatively Regulates T Cell Activation

Immunity

Volumn 18, Issue 6, 2003, Pages 863-873

  Prasad, Durbaka V R ^a   Richards, Sabrina ^a   Mai, Xoi Muoi ^a   Dong, Chen ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; INTERLEUKIN 2; MONOCLONAL ANTIBODY; PROTEIN; PROTEIN B7S1; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL ANCHORAGE; CELL MEMBRANE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOREGULATION; INHIBITION KINETICS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; TISSUE DISTRIBUTION;

EID: 0038433329     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00147-X     Document Type: Article

References (35)

1. Anderson H.A., Hiltbold E.M., Roche P.A. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat. Immunol. 1:2000;156-162.
2. Boise L.H., Petryniak B., Mao X., June C.H., Wang C.Y., Lindsten T., Bravo R., Kovary K., Leiden J.M., Thompson C.B. The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and JunB. Mol. Cell. Biol. 13:1993;1911-1919.
3. Carreno B.M., Collins M. The B7 family of ligands and its receptors. new pathways for costimulation and inhibition of immune responses Annu. Rev. Immunol. 20:2002;29-53.
4. Chambers C.A., Allison J.P. Costimulatory regulation of T cell function. Curr. Opin. Cell Biol. 11:1999;203-210.
5. Chapoval A.I., Ni J., Lau J.S., Wilcox R.A., Flies D.B., Liu D., Dong H., Sica G.L., Zhu G., Tamada K.et al. B7-H3. a costimulatory molecule for t cell activation and ifn-gamma production Nat. Immunol. 2:2001;269-274.
6. Dong C., Wang J., Neame P., Cooper M.D. The murine BP-3 gene encodes a relative of the CD38/NAD glycohydrolase family. Int. Immunol. 6:1994;1353-1360.
7. Dong C., Yang D.D., Wysk M., Whitmarsh A.J., Davis R.J., Flavell R.A. Defective t cell differentiation in the absence of Jnk1. Science. 282:1998;2092-2095.
8. Dong H., Zhu G., Tamada K., Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5:1999;1365-1369.
9. Dong C., Yang D., Tournier C., Whitmarsh A., Xu J., Davis R., Flavell R. JNK is required for effector T-cell function but not for T-cell activation. Nature. 405:2000;91-94.
10. Dong C., Juedes A.E., Temann U.-A., Shresta S., Allison J.P., Ruddle N.H., Flavell R.A. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature. 409:2001;97-102.
11. Frauwirth K.A., Thompson C.B. Activation and inhibition of lymphocytes by costimulation. J. Clin. Invest. 109:2002;295-299.
12. Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H., Fitz L.J., Malenkovich N., Okazaki T., Byrne M.C.et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192:2000;1027-1034.
13. Hutloff A., Dittrich A.M., Beier K.C., Eljaschewitsch B., Kraft R., Anagnostopoulos I., Krocsek R.A. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 397:1999;263-266.
14. Jain J., Loh C., Rao A. Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 7:1995;333-342.
15. Janeway C.A. Jr., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20:2002;197-216.
16. Kontgen F., Grumont R.J., Strasser A., Metcalf D., Li R., Tarlinton D., Gerondakis S. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1995;1965-1977.
17. Kubagawa H., Chen C.C., Ho L.H., Shimada T.S., Gartland L., Mashburn C., Uehara T., Ravetch J.V., Cooper M.D. Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B. J. Exp. Med. 189:1999;309-318.
18. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., Iwai Y., Long A.J., Brown J.A., Nunes R.et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2:2001;261-268.
19. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:1996;233-258.
20. Liang L., Porter E.M., Sha W.C. Constitutive expression of the B7h ligand for inducible costimulator on naive B cells is extinguished after activation by distinct B cell receptor and interleukin 4 receptor-mediated pathways and can be rescued by CD40 signaling. J. Exp. Med. 196:2002;97-108.
21. McAdam A.J., Greenwald R.J., Levin M.A., Chernova T., Malenkovich N., Ling V., Freeman G.J., Sharpe A.H. ICOS is critical for CD40-mediated antibody class switching. Nature. 409:2001;102-105.
22. Mueller D.L., Jenkins M.K., Schwartz R.H. Clonal expansion versus functional clonal inactivation. a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy Annu. Rev. Immunol. 7:1989;445-480.
23. Nishimura H., Nose M., Hiai H., Minato N., Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 11:1999;141-151.
24. Nishimura H., Okazaki T., Tanaka Y., Nakatani K., Hara M., Matsumori A., Sasayama S., Mizoguchi A., Hiai H., Minato N.et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science. 291:2001;319-322.
25. Nurieva R.I., Treuting P., Duong J., Flavell R.A., Dong C. Inducible costimulator is essential for collagen-induced arthritis. J. Clin. Invest. 111:2003;701-706.
26. Peng S.L., Gerth A.J., Ranger A.M., Glimcher L.H. NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity. 14:2001;13-20.
27. Serfling E., Avots A., Neumann M. The architecture of the interleukin-2 promoter. a reflection of T lymphocyte activation Biochim. Biophys. Acta. 1263:1995;181-200.
28. Sun M., Richards S., Prasad D.V., Mai X.M., Rudensky A., Dong C. Characterization of mouse and human B7-H3 genes. J. Immunol. 168:2002;6294-6297.
29. Swallow M.M., Wallin J.J., Sha W.C. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFa. Immunity. 11:1999;423-432.
30. Tafuri A., Shahinian A., Bladt F., Yoshinaga S.K., Jordana M., Wakeham A., Boucher L.-M., Bouchard D., Chan V.S.F., Duncan G.et al. ICOS is essential for effective T-helper-cell responses. Nature. 409:2001;105-109.
31. Thompson C.B., Allison J.P. The emerging role of CTLA-4 as an immune attenuator. Immunity. 7:1997;445-450.
32. Tseng S.Y., Otsuji M., Gorski K., Huang X., Slansky J.E., Pai S.I., Shalabi A., Shin T., Pardoll D.M., Tsuchiya H. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193:2001;839-846.
33. Udenfriend S., Kodukula K. How glycosylphosphatidylinositol-anchored membrane proteins are made. Annu. Rev. Biochem. 64:1995;563-591.
34. Yoshinaga S.K., Whoriskey J.S., Khare S.D., Sarmiento U., Guo J., Horan T., Shih G., Zhang M., Coccia M.A., Kohno T.et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature. 402:1999;827-832.
35. Zhou X.Y., Yashiro-Ohtani Y., Nakahira M., Park W.R., Abe R., Hamaoka T., Naramura M., Gu H., Fujiwara H. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation. J. Immunol. 168:2002;3847-3854.